PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)
China
· Delayed Price · Currency is CNY 40.01
-0.69 (-1.70%)
Apr 29, 2026, 3:04 PM CST
SHE:300725 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 375.61 | 532.74 | 290.2 | 511.19 | 1,150 | 699.63 | Upgrade
|
| Short-Term Investments | - | - | 618.48 | 984.26 | 303.46 | 100.74 | Upgrade
|
| Trading Asset Securities | 687.58 | 735.57 | 465.61 | 105.35 | 163.3 | 304.43 | Upgrade
|
| Cash & Short-Term Investments | 1,063 | 1,268 | 1,374 | 1,601 | 1,617 | 1,105 | Upgrade
|
| Cash Growth | 12.99% | -7.71% | -14.15% | -1.01% | 46.38% | -19.79% | Upgrade
|
| Accounts Receivable | 431.58 | 386.03 | 483.69 | 473.66 | 330.61 | 201.27 | Upgrade
|
| Other Receivables | 3.27 | 2.99 | 1.92 | 2.62 | 1.83 | 2.11 | Upgrade
|
| Receivables | 434.86 | 389.02 | 485.61 | 476.28 | 332.44 | 203.38 | Upgrade
|
| Inventory | 655.42 | 655.24 | 840.17 | 724.79 | 676.39 | 447.94 | Upgrade
|
| Other Current Assets | 492.27 | 363.19 | 16.88 | 15.88 | 33.8 | 47.89 | Upgrade
|
| Total Current Assets | 2,646 | 2,676 | 2,717 | 2,818 | 2,660 | 1,804 | Upgrade
|
| Property, Plant & Equipment | 1,677 | 1,653 | 1,684 | 1,753 | 1,661 | 1,173 | Upgrade
|
| Long-Term Investments | 1,307 | 2,303 | 19.86 | 5.48 | 5.66 | 8.91 | Upgrade
|
| Goodwill | 355.74 | 355.74 | 355.74 | 356.19 | 356.19 | 356.19 | Upgrade
|
| Other Intangible Assets | 102.09 | 103.59 | 107.98 | 109.42 | 111.48 | 111.47 | Upgrade
|
| Long-Term Deferred Tax Assets | 39.12 | 39.82 | 32.63 | 38.61 | 35.8 | 15.1 | Upgrade
|
| Long-Term Deferred Charges | 14.81 | 10.13 | 6.94 | 10.14 | 9.18 | 7.24 | Upgrade
|
| Other Long-Term Assets | 248.34 | 198.3 | 10.99 | 13.1 | 22.8 | 30.74 | Upgrade
|
| Total Assets | 6,390 | 7,340 | 4,935 | 5,104 | 4,862 | 3,507 | Upgrade
|
| Accounts Payable | 354.09 | 312.75 | 292.2 | 278.7 | 413.47 | 267.35 | Upgrade
|
| Accrued Expenses | 55.05 | 95.54 | 91 | 104.71 | 88.18 | 60.61 | Upgrade
|
| Short-Term Debt | 100.06 | 100.06 | 230.27 | 236.5 | 163.4 | 347.64 | Upgrade
|
| Current Portion of Long-Term Debt | 4.73 | 4.75 | 52.74 | 371.43 | 17.29 | 7.95 | Upgrade
|
| Current Portion of Leases | - | - | 1.26 | 1.99 | - | 1.82 | Upgrade
|
| Current Income Taxes Payable | 25.02 | 32.45 | 16.96 | 15.7 | 0.85 | 0.15 | Upgrade
|
| Current Unearned Revenue | 77.91 | 70.09 | 56.28 | 32.73 | 39.63 | 28.7 | Upgrade
|
| Other Current Liabilities | 8.28 | 6.18 | 8.53 | 14.33 | 16.35 | 74.66 | Upgrade
|
| Total Current Liabilities | 625.13 | 621.82 | 749.23 | 1,056 | 739.18 | 788.88 | Upgrade
|
| Long-Term Debt | - | - | 1,127 | 1,138 | 1,392 | 23.6 | Upgrade
|
| Long-Term Leases | 7.64 | 7.87 | 3.21 | 0.23 | - | - | Upgrade
|
| Long-Term Unearned Revenue | 43.12 | 44.8 | 46.61 | 52.64 | 52.85 | 54.14 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 215.19 | 365.25 | 22.13 | 24.31 | 20.15 | 12.58 | Upgrade
|
| Total Liabilities | 891.08 | 1,040 | 1,948 | 2,272 | 2,205 | 879.21 | Upgrade
|
| Common Stock | 233.81 | 233.81 | 199.73 | 199.66 | 199.66 | 199.7 | Upgrade
|
| Additional Paid-In Capital | 2,338 | 2,338 | 1,096 | 1,090 | 1,075 | 1,299 | Upgrade
|
| Retained Earnings | 1,873 | 1,824 | 1,597 | 1,439 | 1,261 | 967.1 | Upgrade
|
| Treasury Stock | -30.04 | -30.04 | -30.04 | -20.03 | - | -35 | Upgrade
|
| Comprehensive Income & Other | 1,085 | 1,935 | 125.24 | 123.52 | 121.74 | -3.44 | Upgrade
|
| Total Common Equity | 5,499 | 6,300 | 2,988 | 2,832 | 2,658 | 2,427 | Upgrade
|
| Minority Interest | - | - | - | - | 0 | 200.29 | Upgrade
|
| Shareholders' Equity | 5,499 | 6,300 | 2,988 | 2,832 | 2,658 | 2,628 | Upgrade
|
| Total Liabilities & Equity | 6,390 | 7,340 | 4,935 | 5,104 | 4,862 | 3,507 | Upgrade
|
| Total Debt | 112.42 | 112.67 | 1,414 | 1,749 | 1,573 | 381.02 | Upgrade
|
| Net Cash (Debt) | 950.77 | 1,156 | -39.71 | -147.83 | 44.11 | 723.78 | Upgrade
|
| Net Cash Growth | - | - | - | - | -93.91% | -42.42% | Upgrade
|
| Net Cash Per Share | 4.38 | 5.53 | -0.20 | -0.73 | 0.22 | 3.63 | Upgrade
|
| Filing Date Shares Outstanding | 232.79 | 231.48 | 198.89 | 198.83 | 199.66 | 199.7 | Upgrade
|
| Total Common Shares Outstanding | 232.79 | 231.48 | 198.89 | 198.83 | 199.66 | 199.7 | Upgrade
|
| Working Capital | 2,021 | 2,054 | 1,968 | 1,762 | 1,921 | 1,015 | Upgrade
|
| Book Value Per Share | 23.62 | 27.22 | 15.02 | 14.24 | 13.31 | 12.16 | Upgrade
|
| Tangible Book Value | 5,041 | 5,841 | 2,524 | 2,367 | 2,190 | 1,960 | Upgrade
|
| Tangible Book Value Per Share | 21.65 | 25.23 | 12.69 | 11.90 | 10.97 | 9.81 | Upgrade
|
| Buildings | - | - | 950.4 | 905.31 | 844.6 | 344.88 | Upgrade
|
| Machinery | - | - | 1,052 | 1,025 | 792.72 | 510.13 | Upgrade
|
| Construction In Progress | - | - | 232.68 | 256.23 | 357.53 | 575.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.